Patents by Inventor Haruhiko Inufusa

Haruhiko Inufusa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and uses thereof
    Patent number: 9603847
    Abstract: Compositions and their use in the treatment or prevention of hyperglycemia and related diseases or disorders are disclosed.
    Type: Grant
    Filed: November 27, 2013
    Date of Patent: March 28, 2017
    Assignee: TIMA Foundation
    Inventors: Markus Matuschka-Greiffenclau, Haruhiko Inufusa
  • Composition for protection against cell-damaging effects
    Patent number: 9089548
    Abstract: The present invention relates to a composition consisting of Vitamin C, L-glutamine, L-cystine or L-cysteine, riboflavin, succinic acid, fumaric acid, coenzyme Q10, and niacin. The present invention relates further to the use of the composition for minimizing the cell-damaging effect of radicals and harmful forms of oxygen, in particular of oxygen radicals or reactive oxygen species. The present invention relates to a composition comprising Vitamin C, L-glutamine, L-cystine or L-cysteine, riboflavin, succinic acid, fumaric acid, coenzyme Q10, and niacin, wherein the composition is administered in a concentration ranging from 10 to 20 mg/kg body weight. The present invention relates further to the composition for use in the treatment and/or prevention of radical and harmful forms of oxygen derived diseases, in particular of oxygen radical or reactive oxygen species derived diseases. The present invention relates further to the composition as a food supplement or dietary supplement.
    Type: Grant
    Filed: November 15, 2012
    Date of Patent: July 28, 2015
    Assignee: Tima Foundation
    Inventor: Haruhiko Inufusa
  • COMPOSITION FOR PROTECTION AGAINST CELL-DAMAGING EFFECTS
    Publication number: 20140314731
    Abstract: The present invention relates to a composition consisting of Vitamin C, L-glutamine, L-cystine or L-cysteine, riboflavin, succinic acid, fumaric acid, coenzyme Q10, and niacin. The present invention relates further to the use of the composition for minimizing the cell-damaging effect of radicals and harmful forms of oxygen, in particular of oxygen radicals or reactive oxygen species. The present invention relates to a composition comprising Vitamin C, L-glutamine, L-cystine or L-cysteine, riboflavin, succinic acid, fumaric acid, coenzyme Q10, and niacin, wherein the composition is administered in a concentration ranging from 10 to 20 mg/kg body weight. The present invention relates further to the composition for use in the treatment and/or prevention of radical and harmful forms of oxygen derived diseases, in particular of oxygen radical or reactive oxygen species derived diseases. The present invention relates further to the composition as a food supplement or dietary supplement.
    Type: Application
    Filed: November 15, 2012
    Publication date: October 23, 2014
    Applicant: TIMA FOUNDATION
    Inventor: Haruhiko Inufusa
  • Novel Compositions and Uses Thereof
    Publication number: 20140086894
    Abstract: Compositions and their use in the treatment or prevention of hyperglycemia and related diseases or disorders are disclosed.
    Type: Application
    Filed: November 27, 2013
    Publication date: March 27, 2014
    Applicant: TIMA FOUNDATION
    Inventors: Markus MATUSCHKA-GREIFFENCLAU, Haruhiko INUFUSA
  • Compositions and uses thereof
    Patent number: 8633192
    Abstract: Compositions and their use in the treatment or prevention of hyperglycemia and related diseases or disorders are disclosed.
    Type: Grant
    Filed: December 14, 2007
    Date of Patent: January 21, 2014
    Assignee: TIMA Foundation
    Inventors: Markus Matuschka-Greiffenclau, Haruhiko Inufusa
  • Optimized oral glucose tolerance test
    Patent number: 7886697
    Abstract: Described herein is a method of enhancing the reliability and reproducibility of animal experiments. As described herein, the method relates to an improved oral glucose tolerance test (OGTT) in animals, wherein the set up of the test has been optimized in comparison to the standard procedure for OGTT.
    Type: Grant
    Filed: December 6, 2007
    Date of Patent: February 15, 2011
    Assignee: TIMA Foundation
    Inventor: Haruhiko Inufusa
  • OPTIMIZED ORAL GLUCOSE TOLERANCE TEST
    Publication number: 20090145366
    Abstract: Described herein is a method of enhancing the reliability and reproducibility of animal experiments. As described herein, the method relates to an improved oral glucose tolerance test (OGTT) in animals, wherein the set up of the test has been optimized in comparison to the standard procedure for OGTT.
    Type: Application
    Filed: December 6, 2007
    Publication date: June 11, 2009
    Applicant: TIMA FOUNDATION
    Inventor: Haruhiko INUFUSA
  • NOVEL COMPOSITIONS AND USES THEREOF
    Publication number: 20080161318
    Abstract: Compositions and their use in the treatment or prevention of hyperglycemia and related diseases or disorders are disclosed.
    Type: Application
    Filed: December 14, 2007
    Publication date: July 3, 2008
    Applicant: TIMA FOUNDATION
    Inventors: Markus MATUSCHKA-GREIFFENCLAU, Haruhiko INUFUSA